Manchester aims to become one of the top five integrated cancer systems globally, through transformational changes in the delivery of services and integration of these with Manchester’s world leading research and education expertise.
Cancer services are provided at a number of sites across the region, with our partners providing leadership in lung cancer and breast cancer.
Manchester is uniquely placed in the area of cancer with world-leading basic science research co-located with the largest single site cancer centre in Europe − Cancer Research UK Manchester Institute and Division of Cancer Sciences researchers (part of The University of Manchester) are based on The Christie NHS Foundation Trust site.
This co-location provides an ideal opportunity to support research that goes from bench to bedside, supporting the integration of clinical and basic scientists so that laboratory-based research is rapidly translated into the clinic. Research is co-ordinated through the Manchester Cancer Research Centre (MCRC). Through the work of the world-class MCRC, leading research in Manchester has helped to improve survival rates among children with Acute Lymphoblastic Leukaemia by 10% in the UK.
The Christie NHS Foundation Trust also launched mobile chemotherapy units in 2014 and now provide 70% of appropriate treatments close to patients’ homes. The Christie is the tertiary cancer service for a population of 3.2 million people from across Greater Manchester and Cheshire. It treats more than 44,000 patients each year with 27% coming from outside of Greater Manchester and Cheshire.
The Christie was the first UK member audited and accredited as a Comprehensive Cancer Centre by the Organisation of European Cancer Institutes; meeting quality standards in care, education and research.